Package Leaflet: Information for the User
VARDENAFIL FLAS QUALIGEN 10 MG ORODISPERSIBLE TABLETS EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
This medication contains vardenafil, an active substance from the group of medications known as phosphodiesterase 5 inhibitors, which are used to treat erectile dysfunction in adult men, a condition that consists of difficulty in achieving or maintaining an erection.
At least one in ten men has, at some point, problems getting or maintaining an erection. This can be due to physical or psychological causes, or a mixture of both. Regardless of the cause, muscle and blood vessel disorders cause insufficient blood flow to the penis to achieve and maintain an erection.
Vardenafil will only work when you are sexually stimulated. This medication reduces the action of a natural substance in the body that prevents erection. Vardenafil allows you to achieve an erection with sufficient duration to maintain a satisfactory sexual relationship.
Do not take Vardenafil
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Be especially careful with vardenafil
Children and adolescents
Vardenafil should not be used in children or adolescents under 18 years of age.
Other medications and Vardenafil Flas Qualigen
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medication, even those obtained without a prescription.
Some medications can cause problems, especially the following:
Do not use vardenafil tablets in combination with another medication for the treatment of erectile dysfunction, including vardenafil orodispersible tablets.
Taking Vardenafil with food, drinks, and alcohol
Pregnancy and breastfeeding
Vardenafil should not be used in women.
Driving and using machines
In some people, vardenafil can cause dizziness or affect vision. Do not drive or operate tools or machines if you feel dizzy or have vision problems after taking vardenafil.
Vardenafil Flas Qualigen contains aspartame
This medication contains 1.80 mg of aspartame in each orodispersible tablet.
Aspartame is a source of phenylalanine, which may be harmful in case of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.
Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is 10 mg.
Take a vardenafil tablet 25 to 60 minutes, approximately, before sexual activity. With sexual stimulation, you can achieve an erection from 25 minutes to 4 or 5 hours after taking vardenafil.
Do not take vardenafil film-coated tabletswith any other formulation of vardenafil.
Do not take vardenafilmore than once a day.
If you think the effect of vardenafil is too strong or too weak, inform your doctor. He or she may suggest changing to another formulation of vardenafil with a different dose based on the effect it has on you.
If you take more Vardenafil than you should
Taking too many vardenafil tablets can cause more side effects or produce intense back pain.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you have any further questions on the use of this medication, ask your doctor or pharmacist.
Like all medications, vardenafil can cause side effects, although not everyone gets them. Most of these side effects are mild or moderate.
Some patients have experienced sudden vision loss or partial vision loss, distorted, attenuated, or blurred vision, temporarily or permanently, in one or both eyes. Stop taking vardenafil and contact your doctor immediately.
There have also been reports of sudden hearing loss.
There have been reports of sudden death, rapid or altered heartbeats, heart attacks, chest pain, and cerebral circulation problems (including temporary reduction of blood flow to parts of the brain and cerebral hemorrhage), in men taking vardenafil. Most men who experienced these side effects had pre-existing heart problems before taking this medication. It is not possible to determine if these events were directly related to vardenafil.
The possibility of presenting a side effect is described through the following categories:
Very common side effects:may affect more than 1 in 10 people:
Common side effects:may affect up to 1 in 10 people:
Uncommon side effects:may affect up to 1 in 100 people:
Rare side effects:may affect up to 1 in 1,000 people:
Very rare or unknown frequency side effects:may affect less than 1 in 10,000 people or the frequency cannot be estimated from the available data:
Reporting side effects
If you experience any side effects, talk to your doctor, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date stated on the packaging after "EXP". The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Vardenafil Flas Qualigen
The other ingredients are:
Microcrystalline cellulose, sodium carboxymethyl starch type A (potato), anhydrous colloidal silica, magnesium stearate, aspartame (E951), peppermint flavor: maltodextrin, gum arabic, pulegone, menthofuran, estragole, and sodium stearyl fumarate.
Appearance of the product and pack contents
Vardenafil Flas Qualigen 10 mg orodispersible tablets are round, flat, white or almost white tablets. Each pack contains 4 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Neuraxpharm Spain, S.L.U.
Avda. de Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Manufacturer
Chanelle Medical Unlimited Company
Dublin Road,
Loughrea,
H62 FH90
Ireland
Date of last revision of this leaflet: January 2025
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/.